U.S. Auto Stock News

If you are wondering whether American States Water at around US$76.84 is priced fairly or offering value, it helps to step back and look at what the recent share performance and fundamentals are signaling. Over the short term the stock is up 2.1% over the last week and is roughly flat over the past month with a 0.1% decline, while year to date it is up 6.3% and the 1 year return sits at a 1.8% decline. These moves come as investors continue to react to company specific developments and the...

Halozyme Therapeutics (NasdaqGS:HALO) has entered a new global collaboration with GSK to apply its ENHANZE technology to subcutaneous delivery of multiple oncology products. The agreement includes development of subcutaneous formulations for antibody drug conjugates, expanding ENHANZE into a new class of cancer therapies. The collaboration introduces additional potential royalty streams tied to future use of ENHANZE across GSK’s oncology portfolio. Halozyme Therapeutics, trading at $65.19,...

Oculis Holding secured a formal Special Protocol Assessment from the FDA for its pivotal Phase 3 PIONEER-1 trial of Privosegtor in optic neuritis. The FDA agreement confirms that the PIONEER-1 trial design is adequate to support a potential future NDA submission. In parallel, new findings from the DME AWARE study support further development of OCS-01 eye drops for diabetic macular edema. These updates arrive with NasdaqGM:OCS trading at $31.09, with the stock up 13.1% over the past week and...

RPM International (RPM) drew fresh attention after reporting third quarter fiscal 2026 earnings and sales that exceeded expectations, alongside guidance regarding sales and adjusted EBIT. See our latest analysis for RPM International. The share price has eased back recently, with a 1 month share price return of 4.84% but a 90 day share price return decline of 13.30%, while the 1 year total shareholder return decline of 6.79% contrasts with a 3 year total shareholder return of 32.76%. This...

Investors may be wondering if Phibro Animal Health at around US$43.16 is still offering value after a strong run, or if the easy gains are behind it. The stock has pulled back 18.8% over the last week and 22.5% over the last month, yet it still shows a 15.7% gain year to date and a 96.6% return over the past year. These sharp moves are drawing attention back to what is already priced into Phibro Animal Health and how much of its story is reflected in the current share price. Ongoing interest...

Recent performance puts Apple Hospitality REIT in focus Apple Hospitality REIT (APLE) has drawn fresh attention after a one-month return of about 19% and a gain of roughly 14% over the past three months, prompting investors to reassess the hotel-focused REIT’s recent momentum. See our latest analysis for Apple Hospitality REIT. At a share price of $13.89, Apple Hospitality REIT’s recent 19.43% 1 month share price return and 15.17% year to date share price return contrast with a steadier 1...

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...

Salesforce (CRM) is back in focus after a flurry of AI-centered announcements, including the launch of Agentforce Operations and Merck Animal Health’s decision to deploy Agentforce Life Sciences across its global customer engagement. See our latest analysis for Salesforce. Despite the flurry of AI product launches and partnerships, including Merck Animal Health adopting Agentforce Life Sciences, Salesforce’s recent price action tells a mixed story, with a 1-day share price return of 2.84% and...

NASB Financial (NASB) has put up a clean set of Q2 2026 numbers, with revenue of US$24.2 million and EPS of US$1.30 anchoring the latest report. The company has seen revenue move from US$19.9 million and EPS of US$0.80 in Q2 2025 to US$24.2 million and EPS of US$1.30 in Q2 2026, while trailing twelve month EPS sits at US$4.52 on revenue of US$92.3 million. For investors, the key takeaway is that profitability and margins sit firmly at the center of this update, setting the tone for how the...

If you are wondering whether Equity Residential at around US$65.86 offers good value today, it helps to look past the headline share price and focus on what different valuation methods are signaling. The stock has returned 0.7% over the past week and 9.4% over the last 30 days, while the 1 year return of 1.2% decline contrasts with gains of 6.2% year to date, 18.6% over 3 years and 8.3% over 5 years. Recent coverage around Equity Residential has centered on its position within the US...

Multiple law firms are scrutinizing Merchants Bancorp (MBIN) after Q1 2026 results highlighted a sharp reduction in brokered deposits and higher funding costs, raising fresh questions about the sustainability of the current earnings profile. See our latest analysis for Merchants Bancorp. The stock has been volatile around Q1 2026, with a reported 9.3% single session drop after the earnings release and legal investigations. However, a 41.02% year to date share price return and 50.41% 1 year...

Why SiriusPoint’s latest quarter caught investor attention SiriusPoint (SPNT) put up a busier first quarter, with higher revenue and net income, its strongest core combined ratio in six quarters, and operating return on equity at the top of its target range. See our latest analysis for SiriusPoint. The latest results appear to have kept positive momentum intact, with the share price at US$23.49 and a 90 day share price return of 12.99%, while the three year total shareholder return of 135.84%...

If you are wondering whether Bruker stock is priced attractively or already reflects its prospects, the recent share moves make that question especially timely. The stock last closed at US$43.73, with returns of 19.1% over the past week and 19.3% over the past month, compared with an 8.5% gain over the past year and longer term returns over 3 and 5 years that have been negative. These shorter term gains come after a period where investors have been reassessing many life sciences and tools...

Q1 earnings and business shift put Etsy in focus Etsy (ETSY) is back on investors’ radar after first quarter 2026 results showed revenue of US$631.28 million and net income of US$69.68 million, compared with a loss a year earlier. The company also highlighted a push toward more human centric buyer and seller interactions, which it links to higher engagement and early momentum in key metrics across its marketplaces. See our latest analysis for Etsy. The 1 month share price return of 18.69% and...

Recursion Pharmaceuticals (RXRX) is back in focus after a busy Q1 2026, with fresh clinical data for REC-1245, first patient dosing for REC-4539, and FDA engagement around REC-4881 following promising Phase 2 results. See our latest analysis for Recursion Pharmaceuticals. The clinical updates and Q1 results have come with pressure on the stock, with a 30 day share price return of 2.51% contrasting with a 1 year total shareholder return decline of 25.51%, which points to fading longer term...

In early May 2026, PDD Holdings drew heightened attention as analysts highlighted expectations for a significant year-over-year earnings increase ahead of its 19 May Q1 2026 results, supported by an upgrade from Arete and reiterated positive views from other research firms. Analysts pointed to PDD Holdings' strengthening earnings outlook, international expansion focus, and supply chain improvements as key reasons for their more optimistic stance on the business. We'll now examine how this...

International Paper (IP) is back in focus after Q1 2026 earnings showed higher sales and a shift from loss to profit, even as management highlighted margin pressure, cost inflation, and softer packaging demand. See our latest analysis for International Paper. International Paper's share price has been under pressure, with a 90 day share price return of 28.98% and a year to date share price return of a 17.81% decline. The 3 year total shareholder return of 19.41% contrasts with the 23.24%...

Wondering if Agilent Technologies at US$118.65 is offering solid value or just fair pricing right now? This article breaks down what the current market price might be implying. The stock is up 2.7% over the last week and 4.2% over the last month, even though the year to date return stands at a 14.0% decline and the 1 year return is 10.0%. Taken together, these figures provide a mixed picture of sentiment and recent momentum. Recent coverage has focused on how Agilent Technologies fits into...

BlackSky Technology (BKSY) is back in focus after raising its 2026 revenue and adjusted EBITDA guidance, supported by fully commissioned Gen-3 satellites, a US$99 million Air Force Research Lab contract, and growing subscription demand. See our latest analysis for BlackSky Technology. The sharp 20.4% one day share price decline to US$32.24 came after weaker first quarter results, even as BlackSky highlighted rising demand for Gen-3 subscriptions, a stronger backlog and higher 2026 guidance...

Ziff Davis (ZD) has just wrapped up FY 2025 with fourth quarter revenue of US$406.7 million and basic EPS of roughly US$0.01. Trailing 12 month revenue came in at about US$1.5 billion with basic EPS of US$1.16. Over recent periods, revenue has moved from US$412.8 million in Q4 2024 to US$406.7 million in Q4 2025, and quarterly EPS has ranged from a loss of about US$0.09 in Q3 2025 to US$0.63 in Q2 2025. This sets up a results snapshot where investors are weighing modest profitability against...

Stock performance snapshot Coursera (COUR) has drawn investor attention after recent trading, with the stock closing at US$6.27 and showing mixed total returns across different periods, including the past month, past 3 months, year to date, and over longer horizons. See our latest analysis for Coursera. Recent trading has lifted Coursera’s short term momentum, with a 1-day share price return of 3.98% and a 90-day share price return of 6.09%. However, this sits against a year to date share...

For investors considering whether Waste Connections at around US$153.57 represents fair value or a potential opportunity, this article explains what the current price may indicate. The stock has come under recent pressure, with a 6.8% decline over the last week, a 6.4% decline over the last month, and a 20.8% decline over the last year. This comes despite 3 year and 5 year returns of 9.3% and 32.4% respectively. Recent coverage has examined how the stock's pullback compares with the broader...

Select Water Solutions, Inc. has reported past first-quarter 2026 results, with sales of US$96.74 million, revenue of US$365.96 million, and net income of US$8.61 million, while leaving basic and diluted earnings per share from continuing operations unchanged at US$0.08. The company also reported no share repurchases in the quarter, even though it has previously completed buybacks totaling more than 13.28 million shares across multiple authorizations, which could influence how investors...

Digi International acquired Jolt Software and Particle Industries, reshaping its Internet of Things (IoT) offering. The company reports that these deals, combined with organic growth, have lifted annual recurring revenue (ARR) by 50%. Management highlights strong cash flow as a key support for integrating these acquisitions into the existing business. Digi International (NasdaqGS:DGII) is drawing fresh attention as it leans harder into IoT platforms and recurring software revenue. The stock...